Date: 2025/05/13 - 23:32
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers.
Date: 2025/05/07 - 22:00
Republican leaders are considering drastic cuts to Medicaid funding. The cuts could have a significant impact on low-income households, older adults, children, and people with mental health disorders. Reduced federal funding could also affect access to reproductive health services.
Date: 2025/05/07 - 00:31
Mice fed a low vitamin K diet had lower vitamin K levels in the brain and had poorer cognitive function compared to mice eating a regular diet, in a new study that hints at a link between vitamin K and dementia.
Date: 2025/05/05 - 23:00
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in nearly two-thirds of participants, twice the rate seen with placebo.
Date: 2025/04/29 - 23:00
"Ozempic feet" and "Ozempic mouth" are the latest reported cosmetic side effects from GLP-1 medications used for weight loss. Experts say wrinkles and sagging skin can result from rapid weight loss due to loss of fat and muscle mass in certain areas of the body.